University Hospital Hamburg-Eppendorf Leads Trial to Explore Personalized Medicine in COVID-19

Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.